Stephen Sencer, Emory’s senior vice president and general counsel, will move on from his longtime leadership role, effective Aug. 31. Sencer will maintain a strong connection with Emory and continue to work with Emory Innovations, Inc., and Drug Innovation Ventures at Emory (DRIVE).
Amy Adelman, a deputy general counsel who has served the university for nearly 20 years, will take on the role on an interim basis, President Gregory L. Fenves announced.
Sencer joined Emory in 2001 and became the chief legal officer for Emory University, including Emory Healthcare, in 2010. In that role, he worked closely with academic and health care leaders to position Emory to expand its reach and thrive across all aspects of its mission.
“Steve has made extraordinary contributions to our university,” Fenves says. “On a personal level, Steve has been invaluable as a colleague and collaborator during my first two years at Emory. His knowledge and skill were called upon time and again, especially during the hardest moments of the pandemic. He is candid, thoughtful, but above all else, he has the heart and compassion that are such essential elements of the Emory spirit.”
As part of the team that envisioned and founded DRIVE, Sencer helped set a new standard for what is possible in academic health care — blending startup-level agility and ambition with the expertise of researchers and scientists at a major research university. He also co-founded the Emory-South Africa Drug Discovery Training...
Russia's Defense Ministry is reporting alleged battlefield successes on Max, but some of its claims lack evidence. Even Russian military bloggers are questioning claims that Ukrainian forces have ...